Methylergometrine Maleate Suppliers & Bulk Manufacturers
Available Forms: Injection and Tablets
Available Strengths: 0.2 mg/mL, 0.2 mg
Reference Brands: Methergine® (EU & US)
Category:
Women's Health
Methylergometrine Maleate Injection (0.2 mg/mL) is widely used in OB/GYN care to prevent postpartum hemorrhage by promoting uterine contractions. Trusted brands like Methergine® serve hospitals and clinics across the US and EU, making it essential in maternal health protocols. Ideal for B2B pharmaceutical sourcing.
Methylergometrine Maleate is available in Injection and Tablets
and strengths such as 0.2 mg/mL, 0.2 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Methylergometrine Maleate is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Methylergometrine Maleate can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Methylergometrine Maleate Injection is a vital uterotonic used in women’s health to manage and prevent postpartum hemorrhage (PPH). Commonly available in 0.2 mg/mL ampoules, it promotes strong uterine contractions after delivery, reducing bleeding risk. Marketed under brands like Methergine® (Novartis/Sandoz), it is widely supplied to hospitals, maternity centers, and OB/GYN clinics across the US and EU. With fast action and proven efficacy, methylergometrine is a preferred choice for active management of the third stage of labor. Pharmaceutical B2B buyers source this injectable for emergency obstetric care and delivery room protocols, making it essential in maternal health supply chains.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing